Autologous Transplantation for Multiple Myeloma in the Era of New Drugs: A Phase III Study of the Intergroupe Francophone Du Myelome (IFM/DFCI 2009 Trial)

被引：1

作者：

Attal, Michel ^{[1
]}

Lauwers-Cances, Valerie ^{[2
]}

Hulin, Cyrille ^{[3
]}

Facon, Thierry ^{[4
]}

Caillot, Denis ^{[5
]}

Escoffre, Martine ^{[6
]}

Arnulf, Bertrand ^{[7
]}

Macro, Margaret ^{[8
]}

Belhadj, Karim ^{[9
]}

Garderet, Laurent ^{[10
]}

Roussel, Murielle ^{[11
,12
]}

Mathiot, Claire ^{[13
]}

Avet-Loiseau, Herve ^{[1
]}

Munshi, Nikhil C. ^{[14
,15
]}

Richardson, Paul G. ^{[16
]}

Anderson, Kenneth C. ^{[17
]}

Harousseau, Jean Luc ^{[18
]}

Moreau, Philippe ^{[19
]}

机构：

[1] Inst Univ Canc Toulouse Oncopole, Toulouse, France

[2] CHU Toulouse, Toulouse, France

[3] CHRU Hop Brabois, Nancy, France

[4] CHRU Lille, Hop Claude Huriez, Malad Sang, F-59037 Lille, France

[5] Hop Bocage, Dijon, France

[6] CHU Rennes, Rennes, France

[7] Hop St Louis, Paris, France

[8] CHU Caen, F-14000 Caen, France

[9] CHU Henri Mondor, F-94010 Creteil, France

[10] Hop St Antoine, F-75571 Paris, France

[11] Inst Univ Canc, Toulouse, France

[12] Univ Hosp, Dept Hematol, Toulouse, France

[13] IFM, Paris, France

[14] Harvard Univ, Sch Med, Dana Farber Canc Inst, LeBow Inst Myeloma Therapeut, Boston, MA 02115 USA

[15] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA

[16] Harvard Univ, Sch Med, Dana Farber Canc Inst,Div Hematol Malignancy, Jerome Lipper Multiple Myeloma Ctr,Dept Med Oncol, Boston, MA 02115 USA

[17] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA

[18] HAS, Paris, France

[19] Nantes Univ Hosp, Dept Hematol, Nantes, France

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] Phase III Studies Published by the IFM (Intergroupe Francophone du Myelome)
Moreau, Philip
CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S33 - S34
[2] Double autologous transplantation improves survival of multiple myeloma patients: Final analysis of a prospective randomized study of the "Intergroupe Francophone du Myelome" (IFM 94).
Attal, M
Harousseau, JL
Facon, T
Guilhot, F
Doyen, C
Fuzibet, JG
Monconduit, M
Hullen, C
Caillot, D
Bouabdallah, R
Voillat, L
Sotto, JJ
Grosbois, B
Bataille, R
BLOOD, 2002, 100 (11) : 5A - 6A
[3] Lenalidomide After Autologous Transplantation for Myeloma: First Analysis of a Prospective, Randomized Study of the Intergroupe Francophone Du Myelome (IFM 2005 02)
Attal, Michel
Harousseau, Jean Luc
Marit, Gerald
Caillot, Denis
Stoppa, Anne Marie
Benboubker, Lofti
Facon, Thierry
Hulin, Cyrille
Garderet, Laurent
Lamy, Thierry
Leyvraz, Serge
Doyen, Chantal
Michallet, Mauricette
Voillat, Laurent
Dumonte, Charles
Roussel, Murielle
Lauwers-Cances, Vallery
Cristini, Christelle
Escriva, Chantal
Petillon, Marie-Odile
Mathiot, Claire
Avet-Loiseau, Herve
Moreau, Philippe
BLOOD, 2009, 114 (22) : 220 - 221
[4] Maintenance treatment with thalidomide after autologous transplantation for myeloma: First analysis of a prospective randomized study of the intergroupe Francophone du Myelome (IFM 99 02).
Attal, M
Harousseau, JL
Leyvraz, S
Doyen, C
Hulin, C
Benboubker, L
Facon, T
Bourhis, JH
Garderet, L
Sotto, JJ
Michallet, M
Renaud, M
Voillat, L
Berthou, C
Marrit, G
Monconduit, M
Coiffier, B
Caillot, D
BLOOD, 2004, 104 (11) : 155A - 155A
[5] Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM)
Roussel, Murielle
Moreau, Philippe
Huynh, Anne
Mary, Jean-Yves
Danho, Clotaire
Caillot, Denis
Hulin, Cyrille
Fruchart, Christophe
Marit, Gerald
Pegourie, Brigitte
Lenain, Pascal
Araujo, Carla
Kolb, Brigitte
Randriamalala, Edouard
Royer, Bruno
Stoppa, Anne-Marie
Dib, Mammoun
Dorvaux, Veronique
Garderet, Laurent
Mathiot, Claire
Avet-Loiseau, Herve
Harousseau, Jean-Luc
Attal, Michel
BLOOD, 2010, 115 (01) : 32 - 37
[6] Bendamustine, Bortezomib and Dexamethasone (BVD) In Elderly Patients With Multiple Myeloma In First Relapse: Final Analysis Of The Intergroupe Francophone Du Myelome (IFM) 2009-01 Trial
Rodon, Philippe
Hulin, Cyrille
Pegourie, Brigitte
Tiab, Mourad
Anglaret, Bruno
Benboubker, Lotfi
Jardel, Henry
Decaux, Olivier
Kolb, Brigitte
Roussel, Murielle
Garderet, Laurent
Leleu, Xavier
Fitoussi, Olivier
Chaleteix, Carine
Casassus, Philippe
Lenain, Pascal
Royer, Bruno
Banos, Anne
Benramdane, Riad
Cony-Makhoul, Pascale
Dib, Mamoun
Fontan, Jean
Stoppa, Anne-Marie
Traulle, Catherine
Vilque, Jean-Pierre
Petillon, Marie-Odile
Mathiot, Claire
Avet-Loiseau, Herve
Moreau, Philippe
BLOOD, 2013, 122 (21)
[7] Bendamustine, Bortezomib and Dexamethasone (BVD) in Elderly Patients with Multiple Myeloma in First Relapse: Updated Results of the Intergroupe Francophone Du Myelome (IFM) 2009-01 Trial
Rodon, Philippe
Hulin, Cyrille
Pegourie, Brigitte
Tiab, Mourad
Anglaret, Bruno
Benboubker, Lotfi
Jardel, Henry
Decaux, Olivier
Kolb, Brigitte
Roussel, Murielle
Garderet, Laurent
Leleu, Xavier
Fitoussi, Olivier
Chaleteix, Carine
Casassus, Philippe
Lenain, Pascal
Moreau, Philippe
Petillon, Marie Odile
Mathiot, Claire
Avet-Loiseau, Herve
BLOOD, 2012, 120 (21)
[8] BENDAMUSTINE, BORTEZOMIB AND DEXAMETHASONE (BVD) IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA : THE INTERGROUPE FRANCOPHONE DU MYELOME (IFM) 2009-01 PROTOCOL
Rodon, P.
Hulin, C.
Pegourie, B.
Tiab, M.
Anglaret, B.
Benboubker, L.
Jardel, H.
Decaux, O.
Kolb, B.
Roussel, M.
Garderet, L.
Leleu, X.
Royer, B.
Banos, A.
Benramdane, R.
Cony-Makhoul, P.
Dib, M.
Fontan, J.
Stoppa, A.
Traulle, C.
Vilque, J.
Moreau, P.
Mathiot, C.
Avet-Loiseau, H.
HAEMATOLOGICA, 2012, 97 : 342 - 342
[9] Maintenance treatment with thalidomide after autologous transplantation for myeloma:: Final analysis of a prospective randomized study of the "Intergroupe Francophone du Myelome".
Attal, M
Harousseau, JL
Leyvraz, S
Doyen, C
Hulin, C
Benboubker, L
Agha, IY
Bourhis, JH
Garderet, L
Sotto, JJ
Michallet, M
Renaud, M
Voillat, L
Berthou, C
Marit, G
Monconduit, M
Dumonté, C
Caillot, D
Mathiot, C
Avet-Loiseau, H
BLOOD, 2005, 106 (11) : 335A - 335A
[10] Bendamustine, bortezomib, and dexamethasone (BVD) in elderly patients with relapsed/refractory multiple myeloma (RRMM): The Intergroupe Francophone du Myelome (IFM) 2009-01 protocol.
Rodon, Philippe
Hulin, Cyrille
Pegourie, Brigitte
Tiab, Mourad
Anglaret, Bruno
Benboubker, Lotfi
Jardel, Henry
Decaux, Olivier
Kolb, Brigitte
Roussel, Murielle
Garderet, Laurent
Leleu, Xavier
Fitoussi, Olivier
Chaleteix, Carine
Casassus, Philippe
Lenain, Pascal
Moreau, Philippe
Petillon, Marie-Odile
Mathiot, Claire
Avet-Loiseau, Herve
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)

← 1 2 3 4 5 →